Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair thinning affects a minority of people on Wegovy, and in most cases it is temporary. The most common cause is not semaglutide itself but the physical stress of rapid weight loss — a well-documented process called telogen effluvium. Keeping protein intake up, losing weight gradually, and supporting your nutritional status can all help. These are prescription-only medicines requiring clinical assessment, and a prescriber can talk through any concerns before and during treatment. Our detailed page on Wegovy and hair loss covers the mechanism in full; this page focuses on the practical steps you can take to protect your hair while on treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NHS page on semaglutide lists hair loss among Wegovy's uncommon side effects. What the listing does not always explain is the mechanism: in the majority of cases, hair thinning is not a pharmacological effect of semaglutide but a response to the caloric deficit and physical change the body is going through. When weight drops quickly, the body temporarily redirects resources away from non-essential growth. Hair follicles, which are energy-hungry, are among the first things paused. The result is telogen effluvium: more hairs than usual shift into the resting phase at the same time, then shed together several weeks later.
This lag means people often notice the thinning two to four months after weight loss accelerates, which coincides with dose increases, making it easy to blame the medicine rather than the speed of change. In most people the shedding self-limits once weight stabilises. The fuller picture of Wegovy's side-effect profile is worth reading alongside this, because the GI symptoms that commonly accompany treatment can reduce appetite further and make nutrition harder to maintain.
There is no known way to prevent telogen effluvium entirely when significant weight is lost. But the severity and duration can often be reduced.
The most important lever is protein. Hair is almost entirely keratin (a protein) and follicles under physical stress are especially sensitive to shortfall. On Wegovy, appetite can fall substantially, and it takes conscious effort to keep protein intake at a level that supports muscle and hair. Most UK dietary guidance for people managing weight with GLP-1 medicines points to prioritising protein at each meal rather than eating less of everything equally. A registered dietitian can give you a personal target; as a rough reference, adults managing weight typically aim for at least 1.2–1.6 g of protein per kilogram of body weight per day, though your prescriber or dietitian should confirm what is right for your situation.
Micronutrients matter too. Iron deficiency, low ferritin, and poor zinc and biotin status are all associated with hair thinning independently of weight loss, and a calorie-restricted diet can worsen any existing shortfall. If you suspect a deficiency, a blood test through your GP is the most useful first step. Over-the-counter hair supplements are widely marketed but the evidence for most of them is weak, a GP-confirmed deficiency treated with the correct supplement is a different matter from buying a general 'hair and nail' formula.
Losing weight more gradually also helps, which is one reason the titration schedule for Wegovy is deliberately slow. If the pace of loss is being driven partly by appetite suppression, keeping meals regular and nutrient-dense matters more than it might seem. Our page on managing Wegovy's side effects in general has practical meal-planning suggestions that apply here too.
Most hair thinning on Wegovy is benign and self-resolving. But there are circumstances where you should speak to a clinician rather than waiting it out.
Contact your GP or prescriber if: the shedding is severe enough to cause visible patches rather than overall thinning; hair loss continues for more than six months without any sign of slowing; you have other symptoms alongside the hair loss (significant fatigue, feeling cold all the time, rapid heartbeat) that might suggest a thyroid or iron problem; or you are also experiencing persistent nausea or ongoing diarrhoea that is making it genuinely difficult to eat, because a separate nutrition problem may be compounding the hair issue.
Seek urgent medical attention for any symptoms unrelated to hair that suggest a more serious reaction: severe stomach pain that spreads to your back (a symptom associated with pancreatitis, flagged in an MHRA Drug Safety Update for GLP-1 medicines in January 2026, full detail on the MHRA's Drug Safety Update page), signs of dehydration such as dark urine and dizziness, or a suspected allergic reaction. These are not related to hair loss but they are the side effects that most warrant the same-day attention.
If you suspect Wegovy has caused or contributed to hair loss, you can report it using the Yellow Card scheme. The link is at yellowcard.mhra.gov.uk. Reports from patients and their families directly inform the MHRA's ongoing safety monitoring of these medicines.
This is a question our prescribers hear regularly. The honest answer is: it depends. Dose increases are one factor in accelerating weight loss, and if that acceleration is what is triggering the telogen effluvium, a slower titration could in theory reduce the severity. But the right pace for dose increases is a clinical decision that weighs multiple factors (not just hair) and it is not something to change without discussing it with your prescriber first.
Some people find that once they move from the early-dose adjustment period into a stable maintenance phase, both GI side effects and hair shedding settle. Others benefit from pausing a planned dose increase until a particular symptom has resolved. Your prescriber is the right person to make that call, with full knowledge of your health picture. If you are on treatment and want to review how things are going, you can reach the nume team through our support page.
If you are not yet on treatment and wondering how Wegovy fits your situation, take a look at the Wegovy overview or go straight to start your free consultation, where a GPhC-registered prescriber reviews your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.